EVOLUTION OF THE TYPE-1 (Th1)–TYPE-2 (Th2) CYTOKINE PARADIGM
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 13 (1) , 1-9
- https://doi.org/10.1016/s0891-5520(05)70039-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host ResponseThe Journal of Infectious Diseases, 1998
- Chemokines — Chemotactic Cytokines That Mediate InflammationNew England Journal of Medicine, 1998
- Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2sThe Journal of Experimental Medicine, 1998
- Functional diversity of helper T lymphocytesNature, 1996
- Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseasesClinical Microbiology Reviews, 1996
- Present Status of the Use of Cytokines as Adjuvants with Vaccines to Protect Against Infectious DiseasesClinical Infectious Diseases, 1995
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania majorScience, 1994
- Revisiting and revising suppressor T cellsImmunology Today, 1992
- Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.Journal of Clinical Investigation, 1991